Summary of findings table ‐ Systemic therapy vs control
Safety of systemic therapies for the treatment of AIMSS · health problem or population
1 finding from 1 review
- Systemic therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast… 2022 · Cochrane Headline outcomes onlyno estimate extracted10 studies · 1250 participantsVery low